Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and clinical features of hearing loss caused by EYA4 variants.
Shinagawa J, Moteki H, Nishio SY, Ohyama K, Otsuki K, Iwasaki S, Masuda S, Oshikawa C, Ohta Y, Arai Y, Takahashi M, Sakuma N, Abe S, Sakurai Y, Sakaguchi H, Ishino T, Uehara N, Usami SI. Shinagawa J, et al. Among authors: sakuma n. Sci Rep. 2020 Feb 27;10(1):3662. doi: 10.1038/s41598-020-60259-0. Sci Rep. 2020. PMID: 32107406 Free PMC article. Clinical Trial.
Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.
Komatsu M, Shiono O, Taguchi T, Sakuma Y, Nishimura G, Sano D, Sakuma N, Yabuki K, Arai Y, Takahashi M, Isitoya J, Oridate N. Komatsu M, et al. Among authors: sakuma n, sakuma y. Jpn J Clin Oncol. 2014 May;44(5):416-21. doi: 10.1093/jjco/hyu026. Epub 2014 Mar 30. Jpn J Clin Oncol. 2014. PMID: 24688084
[A case report: a repeated cerebrospinal fluid otorrhea].
Arai Y, Sakuma N, Sano D, Takahashi M, Matsuda H, Ikoma R, Sakane S, Niwa K, Cho I, Ishitoya J. Arai Y, et al. Among authors: sakuma n. Nihon Jibiinkoka Gakkai Kaiho. 2013 Mar;116(3):161-4. doi: 10.3950/jibiinkoka.116.161. Nihon Jibiinkoka Gakkai Kaiho. 2013. PMID: 23678672 Japanese.
Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum-Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial.
Nishimura G, Hatakeyama H, Shiono O, Taguri M, Komatsu M, Sano D, Sakuma N, Yabuki K, Arai Y, Shibata K, Chiba Y, Tanabe T, Oridate N. Nishimura G, et al. Among authors: sakuma n. JMIR Res Protoc. 2018 Aug 23;7(8):e11003. doi: 10.2196/11003. JMIR Res Protoc. 2018. PMID: 30139721 Free PMC article.
183 results